AWM
CVS icon

Aberdeen Wealth Management’s CVS Health CVS Stock Holding History

Aberdeen Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,874
Closed -$229K – 170
2024
Q1 		$229K Buy
2,874
+3
+0.1% +$229 0.13% 142
2023
Q4 		$227K Sell
2,871
-73
-2% -$5.2K 0.16% 137
2023
Q3 		$206K Buy
2,944
+2
+0.1% +$142 0.15% 141
2023
Q2 		$203K Sell
2,942
-228
-7% -$16.2K 0.15% 139
2023
Q1 		$236K Buy
3,170
+381
+14% +$31.9K 0.18% 131
2022
Q4 		$260K Buy
2,789
+166
+6% +$16K 0.2% 126
2022
Q3 		$250K Buy
2,623
+1
+0% +$99 0.22% 117
2022
Q2 		$243K Buy
2,622
+2
+0.1% +$195 0.19% 126
2022
Q1 		$265K Buy
2,620
+196
+8% +$20.6K 0.18% 129
2021
Q4 		$250K Buy
2,424
+1
+0% +$92 0.16% 128
2021
Q3 		$206K Buy
+2,423
New +$203K 0.2% 121

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Aberdeen Wealth Management's CVS Position: Q2 2024 in Review

Aberdeen Wealth Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 2,874 shares — an estimated $229K sold.

Aberdeen Wealth Management first reported a position in CVS in Q3 2021 and held it in 11 quarters. The position peaked at $265K in Q1 2022. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Aberdeen Wealth Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Aberdeen Wealth Management sold 2,874 CVS Health shares in Q2 2024, an estimated $229K.
  • Aberdeen Wealth Management first reported a position in CVS Health in Q3 2021 and held it in 11 quarters.
  • Aberdeen Wealth Management's CVS Health position peaked at $265K in Q1 2022.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Aberdeen Wealth Management's 13F filing for Q2 2024, filed 2 Aug 2024.